Precision Biosciences Stock In The News
| DTIL Stock | USD 7.24 0.02 0.28% |
Our overall analysis of Precision BioSciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Precision BioSciences. The specific impact of Precision BioSciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Precision BioSciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Precision BioSciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Precision BioSciences Backtesting and Precision BioSciences Hype Analysis. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.
Precision |
Precision BioSciences Today Top News and Investor Outlook
Precision BioSciences Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Precision and other traded companies coverage with news coverage. We help investors stay connected with Precision headlines for the 25th of November to make an informed investment decision based on correlating the impacts of news items on Precision Stock performance. Please note that trading solely based on the Precision BioSciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Precision BioSciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Precision earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Precision BioSciences that are available to investors today. That information is available publicly through Precision media outlets and privately through word of mouth or via Precision internal channels. However, regardless of the origin, that massive amount of Precision data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Precision BioSciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Precision BioSciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Precision BioSciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Precision BioSciences alpha.
Precision Largest EPS Surprises
Earnings surprises can significantly impact Precision BioSciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-11-08 | 2022-09-30 | -0.26 | -0.22 | 0.04 | 15 | ||
2023-03-09 | 2022-12-31 | -0.21 | -0.26 | -0.05 | 23 | ||
2022-08-08 | 2022-06-30 | -0.41 | -0.46 | -0.05 | 12 | ||
2022-03-15 | 2021-12-31 | -0.47 | -0.52 | -0.05 | 10 | ||
2022-05-09 | 2022-03-31 | -0.54 | -0.46 | 0.08 | 14 | ||
2019-08-14 | 2019-06-30 | -0.47 | -0.39 | 0.08 | 17 |
Precision BioSciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Precision BioSciences Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
22nd of November 2024
Insider Buying John Kelly Acquires Shares of Precision BioSciences Inc at gurufocus.com
15th of November 2024
Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Cl... at businesswire.com
7th of November 2024
What is HC Wainwrights Estimate for DTIL FY2024 Earnings at thelincolnianonline.com
4th of November 2024
Precision BioSciences Q3 Earnings Snapshot at finance.yahoo.com
29th of October 2024
Precision BioSciences to Report Third Quarter Results on November 4, 2024 at businesswire.com
24th of October 2024
Precision BioSciences Receives First Approval of Clinical Trial Application to Initiate PB... at businesswire.com
18th of October 2024
Precision BioSciences, Inc. Short Interest Down 7.1 percent in September at thelincolnianonline.com
16th of October 2024
Precision BioSciences to Present at the European Society of Gene Cell Therapy 31st Annual ... at finance.yahoo.com
4th of October 2024
Cartesian Therapeutics, Inc. Moves 26.9 percent Higher Will This Strength Last at zacks.com
27th of September 2024
Wall Street SWOT Precision BioSciences stock navigates gene editing frontier - Investing.c... at news.google.com
3rd of September 2024
Precision BioSciences Receives 13 Million in Proceeds from Imugene Convertible Note Maturi... at businesswire.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Precision BioSciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Precision BioSciences' short interest history, or implied volatility extrapolated from Precision BioSciences options trading.
Check out Precision BioSciences Backtesting and Precision BioSciences Hype Analysis. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.